\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-contributory\\.\\ \\ non\\-focal\\ neuro\\ exam\\.\ \(0\)\
\-\ neurosurgery\\ was\\ consulted\\ and\\ patient\\ underwent\\ surgery\\ with\\ ventriculo\\-peritoneal\\ shunt\\ placement\\ to\\ alleviate\\ pressure\\ and\\ to\\ prevent\\ any\\ further\\ complications\\.\\ \\ \ \(0\)\
\-\ endoscopic\\ ventriculostomy\\ is\\ an\\ alternative\\ to\\ the\\ shunt\\ surgery\\.\ \(0\)\
\-\ ct\\ imaging\\ without\\ contrast\\ showed\\ ventricular\\ enlargement\\ of\\ lateral\\ and\\ third\\ ventricles\\ with\\ a\\ normal\\ fourth\\ ventricle\\.\\ \\ subsequent\\ mri\\ confirmed\\ the\\ ct\\ findings\\ without\\ evidence\\ of\\ transependymal\\ flow\\ of\\ csf\\.\\ \\ high\\ resolution\\ mri\\ demonstrated\\ multiple\\ thin\\ septations\\ in\\ the\\ aqueduct\\ of\\ sylvius\\.\ \(0\)\
\-\ mr\\ imaging\\ with\\ cine\\ csf\\ flow\\ study\\ \\(not\\ depicted\\)\\ showed\\ no\\ significant\\ csf\\ flow\\ through\\ the\\ cerebral\\ aqueduct\\.\ \(0\)\
\-\ non\\ communicating\\ hydrocephalus\\ due\\ to\\ aqueductal\\ stenosis\ \(0\)\
\-\ communicating\\ vs\\.\\ non\\-communicating\\ hydrocephalus\ \(0\)\
\-\ 21\\ yr\\ old\\ pregnant\\ female\\ at\\ 11\\ wks\\ of\\ gestation\\ presents\\ with\\ two\\ weeks\\ history\\ of\\ severe\\ headache\\.\\ \\ she\\ reports\\ recent\\ mvc\\ one\\ week\\ prior\\ to\\ presentation\\ to\\ the\\ ed\\.\\ \\ subsequently\\,\\ she\\ noted\\ a\\ remote\\ history\\ of\\ salmonella\\ meningitis\\ as\\ a\\ child\\.\ \(0\)\
\-\ hydrocephalus\\ is\\ defined\\ as\\ an\\ active\\ distension\\ of\\ the\\ ventricular\\ system\\ due\\ to\\ inadequate\\ passage\\ of\\ csf\\ from\\ its\\ point\\ of\\ production\\ within\\ the\\ ventricular\\ system\\ to\\ its\\ point\\ of\\ absorption\\ into\\ the\\ systemic\\ circulation\\ \\(2\\)\\.\\ \\ the\\ incidence\\ of\\ hydrocephalus\\ is\\ equal\\ in\\ men\\ and\\ women\\.\\ \\ however\\,\\ there\\ are\\ a\\ few\\ exceptions\\ such\\ as\\ an\\ x\\-linked\\ hydrocephalus\\ and\\ normal\\ pressure\\ hydrocephalus\\ that\\ is\\ predominant\\ in\\ male\\ patients\\.\ \(0\)\
\-\ this\\ 21\\ yr\\ old\\ woman\\ presented\\ with\\ headache\\ and\\ was\\ diagnosed\\ with\\ aqueductal\\ stenosis\\.\\ \\ headache\\ is\\ the\\ most\\ common\\ clinical\\ manifestation\\ of\\ an\\ adult\\ with\\ aqueductal\\ stenosis\\.\\ \\ the\\ signs\\ and\\ symptoms\\ of\\ hydrocephalus\\ vary\\ with\\ age\\ and\\ disease\\ progression\\.\\ \\ a\\ symptomatic\\ adult\\ patient\\ could\\ have\\ additional\\ neurological\\ symptoms\\ such\\ as\\ nausea\\,\\ vomiting\\,\\ blurred\\ and\\ double\\ vision\\,\\ gait\\ impairment\\,\\ drowsiness\\ and\\ cognitive\\ deterioration\\.\\ \\ possible\\ physical\\ exam\\ findings\\ include\\ those\\ due\\ to\\ increased\\ intracranial\\ pressure\\ such\\ as\\ papilledema\\,\\ failure\\ of\\ upward\\ gaze\\ and\\ accommodation\\,\\ enlarged\\ head\\,\\ and\\ gait\\ instability\\(1\\)\\.\\ \\ \ \(0\)\
\-\ based\\ on\\ the\\ imaging\\ findings\\,\\ the\\ patient\\ suffered\\ from\\ chronic\\ hydrocephalus\\ because\\ there\\ was\\ no\\ significant\\ transependymal\\ flow\\ of\\ csf\\ or\\ sulcal\\ effacement\\ \\.\\ \\ chronic\\ hydrocephalus\\ are\\ typically\\ due\\ to\\ congenital\\ causes\\ or\\ longstanding\\ processes\\,\\ and\\ this\\ patient\\â\\€\\™s\\ aqueductal\\ septations\\ are\\ likely\\ associated\\ with\\ post\\-inflammatory\\ changes\\ and\\ sequelae\\ of\\ her\\ childhood\\ case\\ of\\ salmonella\\ meningitis\\.\\ \\ the\\ incidence\\ of\\ chronic\\ hydrocephalus\\ increases\\ with\\ increasing\\ age\\ and\\ clinical\\ symptoms\\ appear\\ when\\ hydrocephalus\\ decompensates\\ due\\ to\\ late\\ onset\\ of\\ aqueductal\\ stenosis\\ \\(3\\,4\\)\\.\\ \\ \ \(0\)\
\-\ in\\ order\\ to\\ relieve\\ the\\ pressure\\ and\\ improve\\ patient\\â\\€\\™s\\ clinical\\ manifestation\\,\\ this\\ patient\\ underwent\\ vp\\ shunt\\ placement\\.\\ \\ currently\\,\\ there\\ are\\ two\\ forms\\ of\\ surgical\\ treatment\\ for\\ aqueductal\\ stenosis\\:\\ shunt\\ placement\\ and\\ endoscopic\\ third\\ ventriculostomy\\.\\ \\ shunt\\ surgery\\ remains\\ the\\ standard\\ of\\ care\\ due\\ to\\ its\\ effectiveness\\,\\ but\\ etv\\ experience\\ is\\ growing\\ with\\ improving\\ patency\\ rates\\ and\\ avoids\\ shunt\\ malfunction\\ complications\\.\\ \\ after\\ obstruction\\ is\\ resolved\\,\\ a\\ patient\\â\\€\\™s\\ gait\\,\\ postural\\ function\\,\\ cognitive\\ functions\\ may\\ improve\\ \\(1\\)\\.\\ \\ this\\ patient\\ had\\ complete\\ resolution\\ of\\ headache\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\	tisell\\,\\ m\\,\\ tullberg\\,\\ m\\,\\ hellstrom\\,\\ p\\,\\ blomsterwall\\,\\ e\\,\\ wikkelso\\,\\ c\\.\\ neurological\\ symptoms\\ and\\ signs\\ in\\ adult\\ aqueductal\\ stenosis\\.\\ acta\\ neurologica\\ scandinavica\\.\\ 2003\\;107\\(5\\)\\:311\\-317\\.\ \(0\)\
\-\ 2\\.\\	rekate\\,\\ hl\\.\\ a\\ contemporary\\ definition\\ and\\ classification\\ of\\ hydrocephalus\\.\\ seminars\\ in\\ pediatric\\ neurology\\.\\ 2009\\;\\ 16\\(1\\)\\:9\\-15\\.\ \(0\)\
\-\ 3\\.\\	partington\\ md\\.\\ congenital\\ hydrocephalus\\.\\ neurosurg\\ clin\\ n\\ am\\.\\ 2001\\;12\\(4\\)\\:737\\-42\\.\\ \ \(0\)\
\-\ 4\\.\\	edwards\\,\\ rj\\,\\ dombrowski\\,\\ sm\\,\\ luciano\\,\\ mg\\,\\ pople\\,\\ ik\\.\\ chronic\\ hydrocephalus\\ in\\ adults\\.\\ brain\\ pathol\\.\\ 2004\\;14\\(3\\)325\\-36\\.\ \(0\)\
\-\ 5\\.\\	tisell\\,\\ m\\.\\ how\\ should\\ primary\\ aqueductal\\ stenosis\\ in\\ adults\\ be\\ treated\\?\\ a\\ review\\.\\ acta\\ neurologica\\ scandinavica\\.\\ 2005\\;111\\(3\\)\\:145\\-153\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.3867477498612388\ \(0\)\
\-\ aqueductal\\:\\ 0\\.3734917754849687\ \(0\)\
\-\ shunt\\:\\ 0\\.19252794439780363\ \(0\)\
\-\ stenosis\\:\\ 0\\.18019294638983982\ \(0\)\
\-\ of\\:\\ 0\\.1589385384477785\ \(0\)\
\-\ and\\:\\ 0\\.13985456448542544\ \(0\)\
\-\ csf\\:\\ 0\\.1336982651035718\ \(0\)\
\-\ due\\:\\ 0\\.11671297441645884\ \(0\)\
\-\ to\\:\\ 0\\.1099808112913154\ \(0\)\
\-\ tisell\\:\\ 0\\.10823670283594312\ \(0\)\
\-\ scandinavica\\:\\ 0\\.10823670283594312\ \(0\)\
\-\ communicating\\:\\ 0\\.10817116374752146\ \(0\)\
\-\ the\\:\\ 0\\.10803854473768433\ \(0\)\
\-\ neurologica\\:\\ 0\\.10342594789899398\ \(0\)\
\-\ pressure\\:\\ 0\\.10306689310635755\ \(0\)\
\-\ adult\\:\\ 0\\.09364498224202092\ \(0\)\
\-\ headache\\:\\ 0\\.0933128154959663\ \(0\)\
\-\ transependymal\\:\\ 0\\.09039115307740547\ \(0\)\
\-\ acta\\:\\ 0\\.09039115307740547\ \(0\)\
\-\ flow\\:\\ 0\\.09016070440863246\ \(0\)\
\-\ patient\\:\\ 0\\.08805296693037482\ \(0\)\
\-\ salmonella\\:\\ 0\\.0880102391107269\ \(0\)\
\-\ gait\\:\\ 0\\.08792638714559807\ \(0\)\
\-\ ventriculostomy\\:\\ 0\\.08697786812971528\ \(0\)\
\-\ ventricular\\:\\ 0\\.08539772016481588\ \(0\)\
\-\ aqueduct\\:\\ 0\\.08216711319276612\ \(0\)\
\-\ chronic\\:\\ 0\\.08034705127346148\ \(0\)\
\-\ placement\\:\\ 0\\.07927527346161234\ \(0\)\
\-\ cognitive\\:\\ 0\\.07826948419734585\ \(0\)\
\-\ yr\\:\\ 0\\.07692486410196347\ \(0\)\
\-\ manifestation\\:\\ 0\\.07692486410196347\ \(0\)\
\-\ its\\:\\ 0\\.07512107148532725\ \(0\)\
\-\ symptoms\\:\\ 0\\.07406245254430005\ \(0\)\
\-\ septations\\:\\ 0\\.07330157753832625\ \(0\)\
\-\ with\\:\\ 0\\.07289035608553789\ \(0\)\
\-\ endoscopic\\:\\ 0\\.07077958246161253\ \(0\)\
\-\ as\\:\\ 0\\.06797468048534926\ \(0\)\
\-\ in\\:\\ 0\\.06734737597902624\ \(0\)\
\-\ improve\\:\\ 0\\.06571903342348745\ \(0\)\
\-\ such\\:\\ 0\\.06530383304549359\ \(0\)\
\-\ is\\:\\ 0\\.06487218561475087\ \(0\)\
\-\ clinical\\:\\ 0\\.06433958373661403\ \(0\)\
\-\ non\\:\\ 0\\.06422654680189735\ \(0\)\
\-\ meningitis\\:\\ 0\\.06374965602554013\ \(0\)\
\-\ adults\\:\\ 0\\.06320405270202244\ \(0\)\
\-\ incidence\\:\\ 0\\.05826072899419866\ \(0\)\
\-\ point\\:\\ 0\\.055951941581295205\ \(0\)\
\-\ neurological\\:\\ 0\\.05559561505519066\ \(0\)\
\-\ resolution\\:\\ 0\\.054913543279068035\ \(0\)\
\-\ surgery\\:\\ 0\\.05458227735681199\ \(0\)\
\-\ decompensates\\:\\ 0\\.05411835141797156\ \(0\)\
\-\ etv\\:\\ 0\\.05411835141797156\ \(0\)\
\-\ avoids\\:\\ 0\\.05411835141797156\ \(0\)\
\-\ tullberg\\:\\ 0\\.05411835141797156\ \(0\)\
\-\ blomsterwall\\:\\ 0\\.05411835141797156\ \(0\)\
\-\ wikkelso\\:\\ 0\\.05411835141797156\ \(0\)\
\-\ rekate\\:\\ 0\\.05411835141797156\ \(0\)\
\-\ partington\\:\\ 0\\.05411835141797156\ \(0\)\
\-\ dombrowski\\:\\ 0\\.05411835141797156\ \(0\)\
\-\ luciano\\:\\ 0\\.05411835141797156\ \(0\)\
\-\ pople\\:\\ 0\\.05411835141797156\ \(0\)\
\-\ ik\\:\\ 0\\.05411835141797156\ \(0\)\
\-\ 21\\:\\ 0\\.054081708591157907\ \(0\)\
\-\ imaging\\:\\ 0\\.0533530084398959\ \(0\)\
\-\ complications\\:\\ 0\\.05183639360391537\ \(0\)\
\-\ an\\:\\ 0\\.05176199816495655\ \(0\)\
\-\ hellstrom\\:\\ 0\\.05171297394949699\ \(0\)\
\-\ edwards\\:\\ 0\\.05171297394949699\ \(0\)\
\-\ system\\:\\ 0\\.05163357188625559\ \(0\)\
\-\ third\\:\\ 0\\.05153344655317878\ \(0\)\
\-\ are\\:\\ 0\\.05136374632920151\ \(0\)\
\-\ findings\\:\\ 0\\.0501049552784724\ \(0\)\
\-\ sylvius\\:\\ 0\\.050006331475651894\ \(0\)\
\-\ drowsiness\\:\\ 0\\.050006331475651894\ \(0\)\
\-\ exceptions\\:\\ 0\\.04868255672948208\ \(0\)\
\-\ malfunction\\:\\ 0\\.04868255672948208\ \(0\)\
\-\ seminars\\:\\ 0\\.04868255672948208\ \(0\)\
\-\ congenital\\:\\ 0\\.04862945788440823\ \(0\)\
\-\ hl\\:\\ 0\\.047600954007177315\ \(0\)\
\-\ signs\\:\\ 0\\.047301576256261434\ \(0\)\
\-\ contemporary\\:\\ 0\\.04668647193562109\ \(0\)\
\-\ underwent\\:\\ 0\\.04662340416186913\ \(0\)\
\-\ this\\:\\ 0\\.04651284220162839\ \(0\)\
\-\ alleviate\\:\\ 0\\.045894311533332226\ \(0\)\
\-\ accommodation\\:\\ 0\\.045195576538702736\ \(0\)\
\-\ functions\\:\\ 0\\.045195576538702736\ \(0\)\
\-\ showed\\:\\ 0\\.04508035220431623\ \(0\)\
\-\ depicted\\:\\ 0\\.04457053678716241\ \(0\)\
\-\ effectiveness\\:\\ 0\\.04457053678716241\ \(0\)\
\-\ cine\\:\\ 0\\.04400511955536345\ \(0\)\
\-\ sm\\:\\ 0\\.04400511955536345\ \(0\)\
\-\ pathol\\:\\ 0\\.04400511955536345\ \(0\)\
\-\ absorption\\:\\ 0\\.04301408944394328\ \(0\)\
\-\ rj\\:\\ 0\\.04301408944394328\ \(0\)\
\-\ age\\:\\ 0\\.04249082131931227\ \(0\)\
\-\ neurosurg\\:\\ 0\\.04216515931868783\ \(0\)\
\-\ wks\\:\\ 0\\.04178229159101255\ \(0\)\
\-\ sulcal\\:\\ 0\\.04178229159101255\ \(0\)\
\-\ vp\\:\\ 0\\.04108355659638306\ \(0\)\
\-\ patency\\:\\ 0\\.0407628087114828\ \(0\)\
\-\ mvc\\:\\ 0\\.04045851684484274\ \(0\)\
\-\ deterioration\\:\\ 0\\.04045851684484274\ \(0\)\
\-\ upward\\:\\ 0\\.04045851684484274\ \(0\)\
\-\ there\\:\\ 0\\.0403951083069546\ \(0\)\
\-\ she\\:\\ 0\\.04028890529694565\ \(0\)\
\-\ two\\:\\ 0\\.040192677830651544\ \(0\)\
\-\ alternative\\:\\ 0\\.040169074524826834\ \(0\)\
\-\ postural\\:\\ 0\\.040169074524826834\ \(0\)\
\-\ gaze\\:\\ 0\\.039893099613043784\ \(0\)\
\-\ 107\\:\\ 0\\.039893099613043784\ \(0\)\
\-\ blurred\\:\\ 0\\.03962939438666622\ \(0\)\
\-\ improving\\:\\ 0\\.03962939438666622\ \(0\)\
\-\ inadequate\\:\\ 0\\.03937691412253797\ \(0\)\
\-\ longstanding\\:\\ 0\\.03937691412253797\ \(0\)\
\-\ significant\\:\\ 0\\.03907753637162208\ \(0\)\
\-\ predominant\\:\\ 0\\.03805313937636816\ \(0\)\
\-\ vary\\:\\ 0\\.03805313937636816\ \(0\)\
\-\ passage\\:\\ 0\\.037310622701259545\ \(0\)\
\-\ papilledema\\:\\ 0\\.037310622701259545\ \(0\)\
\-\ suffered\\:\\ 0\\.037310622701259545\ \(0\)\
\-\ definition\\:\\ 0\\.037310622701259545\ \(0\)\
\-\ relieve\\:\\ 0\\.037138657304811924\ \(0\)\
\-\ 111\\:\\ 0\\.03680899523224067\ \(0\)\
\-\ consulted\\:\\ 0\\.036650788769163126\ \(0\)\
\-\ circulation\\:\\ 0\\.036650788769163126\ \(0\)\
\-\ 2009\\:\\ 0\\.03649669203314903\ \(0\)\
\-\ production\\:\\ 0\\.03634649690252307\ \(0\)\
\-\ impairment\\:\\ 0\\.03605705458250716\ \(0\)\
\-\ sequelae\\:\\ 0\\.03591746247664985\ \(0\)\
\-\ neurology\\:\\ 0\\.03578107967072411\ \(0\)\
\-\ how\\:\\ 0\\.03578107967072411\ \(0\)\
\-\ without\\:\\ 0\\.035699199259383765\ \(0\)\
\-\ pregnant\\:\\ 0\\.03551737444434655\ \(0\)\
\-\ increases\\:\\ 0\\.03551737444434655\ \(0\)\
\-\ clin\\:\\ 0\\.03551737444434655\ \(0\)\
\-\ was\\:\\ 0\\.03538126408647481\ \(0\)\
\-\ forms\\:\\ 0\\.0352648941802183\ \(0\)\
\-\ rates\\:\\ 0\\.0352648941802183\ \(0\)\
\-\ distension\\:\\ 0\\.035142572510950924\ \(0\)\
\-\ remote\\:\\ 0\\.035022722156353256\ \(0\)\
\-\ classification\\:\\ 0\\.03479004955930394\ \(0\)\
\-\ mri\\:\\ 0\\.03474143599100485\ \(0\)\
\-\ men\\:\\ 0\\.034457304924554295\ \(0\)\
\-\ neurosurgery\\:\\ 0\\.03424541130068855\ \(0\)\
\-\ childhood\\:\\ 0\\.03424541130068855\ \(0\)\
\-\ exam\\:\\ 0\\.03407066487772151\ \(0\)\
\-\ experience\\:\\ 0\\.03365167711403258\ \(0\)\
\-\ gestation\\:\\ 0\\.03355825170637321\ \(0\)\
\-\ effacement\\:\\ 0\\.03355825170637321\ \(0\)\
\-\ processes\\:\\ 0\\.03328649163723908\ \(0\)\
\-\ growing\\:\\ 0\\.03319860275893988\ \(0\)\
\-\ equal\\:\\ 0\\.03238467209082936\ \(0\)\
\-\ remains\\:\\ 0\\.032234476960203394\ \(0\)\
\-\ 2005\\:\\ 0\\.032160781717114235\ \(0\)\
\-\ late\\:\\ 0\\.031945034640187484\ \(0\)\
\-\ am\\:\\ 0\\.031945034640187484\ \(0\)\
\-\ 2001\\:\\ 0\\.031945034640187484\ \(0\)\
\-\ instability\\:\\ 0\\.031874828012770064\ \(0\)\
\-\ 2004\\:\\ 0\\.031874828012770064\ \(0\)\
\-\ neuro\\:\\ 0\\.03153574196557391\ \(0\)\
\-\ standard\\:\\ 0\\.031405354502026875\ \(0\)\
\-\ order\\:\\ 0\\.03127777128848659\ \(0\)\
\-\ prevent\\:\\ 0\\.031030552568631256\ \(0\)\
\-\ progression\\:\\ 0\\.031030552568631256\ \(0\)\
\-\ md\\:\\ 0\\.030851672963034028\ \(0\)\
\-\ women\\:\\ 0\\.030454139243269143\ \(0\)\
\-\ 2003\\:\\ 0\\.030454139243269143\ \(0\)\
\-\ resolved\\:\\ 0\\.030399462443513114\ \(0\)\
\-\ fourth\\:\\ 0\\.030345284982234624\ \(0\)\
\-\ pediatric\\:\\ 0\\.03029159782144641\ \(0\)\
\-\ systemic\\:\\ 0\\.030030216744277353\ \(0\)\
\-\ double\\:\\ 0\\.02982909949172881\ \(0\)\
\-\ ventricles\\:\\ 0\\.029731041213253106\ \(0\)\
\-\ mg\\:\\ 0\\.02953965717171291\ \(0\)\
\-\ vision\\:\\ 0\\.02930879571519936\ \(0\)\
\-\ those\\:\\ 0\\.028957143701053577\ \(0\)\
\-\ subsequently\\:\\ 0\\.02887239382001202\ \(0\)\
\-\ few\\:\\ 0\\.02870644199810754\ \(0\)\
\-\ child\\:\\ 0\\.028012254639407017\ \(0\)\
\-\ review\\:\\ 0\\.027868432061446572\ \(0\)\
\-\ normal\\:\\ 0\\.027633711153640796\ \(0\)\
\-\ function\\:\\ 0\\.02739085550828093\ \(0\)\
\-\ intracranial\\:\\ 0\\.027229199980699947\ \(0\)\
\-\ ed\\:\\ 0\\.02707183290790026\ \(0\)\
\-\ references\\:\\ 0\\.026979378193326395\ \(0\)\
\-\ from\\:\\ 0\\.026880036151323006\ \(0\)\
\-\ increasing\\:\\ 0\\.02665219604447779\ \(0\)\
\-\ appear\\:\\ 0\\.02665219604447779\ \(0\)\
\-\ 16\\:\\ 0\\.026369647845840692\ \(0\)\
\-\ thin\\:\\ 0\\.02634211930094947\ \(0\)\
\-\ reports\\:\\ 0\\.026314717909143713\ \(0\)\
\-\ additional\\:\\ 0\\.02623326503991495\ \(0\)\
\-\ symptomatic\\:\\ 0\\.026021371416049204\ \(0\)\
\-\ nausea\\:\\ 0\\.02599540905172869\ \(0\)\
\-\ currently\\:\\ 0\\.02599540905172869\ \(0\)\
\-\ enlargement\\:\\ 0\\.02594382271989904\ \(0\)\
\-\ history\\:\\ 0\\.025858071961222986\ \(0\)\
\-\ vs\\:\\ 0\\.025816785943127796\ \(0\)\
\-\ ct\\:\\ 0\\.025766803960738358\ \(0\)\
\-\ failure\\:\\ 0\\.025692412608344962\ \(0\)\
\-\ subsequent\\:\\ 0\\.02561902127093343\ \(0\)\
\-\ causes\\:\\ 0\\.02557059332217302\ \(0\)\
\-\ 11\\:\\ 0\\.025334211821733867\ \(0\)\
\-\ 14\\:\\ 0\\.02526509580757051\ \(0\)\
\-\ active\\:\\ 0\\.025129233592297445\ \(0\)\
\-\ vomiting\\:\\ 0\\.025040357161775748\ \(0\)\
\-\ confirmed\\:\\ 0\\.024952792608478876\ \(0\)\
\-\ ventricle\\:\\ 0\\.024909490293745135\ \(0\)\
\-\ could\\:\\ 0\\.02461491392686719\ \(0\)\
\-\ diagnosed\\:\\ 0\\.024513155157837002\ \(0\)\
\-\ based\\:\\ 0\\.024513155157837002\ \(0\)\
\-\ care\\:\\ 0\\.02417967681573638\ \(0\)\
\-\ defined\\:\\ 0\\.02414164853949838\ \(0\)\
\-\ typically\\:\\ 0\\.0237564121191269\ \(0\)\
\-\ complete\\:\\ 0\\.023720994755548144\ \(0\)\
\-\ obstruction\\:\\ 0\\.02370336505229473\ \(0\)\
\-\ because\\:\\ 0\\.023650788128130717\ \(0\)\
\-\ or\\:\\ 0\\.02354502554451049\ \(0\)\
\-\ cerebral\\:\\ 0\\.02344501984376509\ \(0\)\
\-\ presentation\\:\\ 0\\.02329524606267436\ \(0\)\
\-\ 12\\:\\ 0\\.023133148798436448\ \(0\)\
\-\ enlarged\\:\\ 0\\.023069530057069517\ \(0\)\
\-\ possible\\:\\ 0\\.022928834353259285\ \(0\)\
\-\ recent\\:\\ 0\\.02291340549988414\ \(0\)\
\-\ week\\:\\ 0\\.022761284580967014\ \(0\)\
\-\ study\\:\\ 0\\.02256918540582595\ \(0\)\
\-\ should\\:\\ 0\\.02208093424637239\ \(0\)\
\-\ further\\:\\ 0\\.022040895461459743\ \(0\)\
\-\ no\\:\\ 0\\.02200910117015153\ \(0\)\
\-\ mr\\:\\ 0\\.02189635608895164\ \(0\)\
\-\ any\\:\\ 0\\.021870450411196462\ \(0\)\
\-\ onset\\:\\ 0\\.021729956657677442\ \(0\)\
\-\ severe\\:\\ 0\\.02142251010296579\ \(0\)\
\-\ her\\:\\ 0\\.02114163441372202\ \(0\)\
\-\ brain\\:\\ 0\\.021096088003592934\ \(0\)\
\-\ treated\\:\\ 0\\.021073445263208517\ \(0\)\
\-\ primary\\:\\ 0\\.020808266333984273\ \(0\)\
\-\ demonstrated\\:\\ 0\\.020797470351425464\ \(0\)\
\-\ changes\\:\\ 0\\.020451796418178816\ \(0\)\
\-\ when\\:\\ 0\\.02044162950775753\ \(0\)\
\-\ weeks\\:\\ 0\\.02028128486091966\ \(0\)\
\-\ likely\\:\\ 0\\.020222255609920105\ \(0\)\
\-\ head\\:\\ 0\\.020183226582443946\ \(0\)\
\-\ through\\:\\ 0\\.020144452648472824\ \(0\)\
\-\ include\\:\\ 0\\.020134798633683535\ \(0\)\
\-\ old\\:\\ 0\\.020030862953644354\ \(0\)\
\-\ however\\:\\ 0\\.02002962859717871\ \(0\)\
\-\ presented\\:\\ 0\\.019733871863816442\ \(0\)\
\-\ one\\:\\ 0\\.01937528369256453\ \(0\)\
\-\ high\\:\\ 0\\.019232731754894677\ \(0\)\
\-\ evidence\\:\\ 0\\.019207927297383184\ \(0\)\
\-\ common\\:\\ 0\\.01919144842351269\ \(0\)\
\-\ patients\\:\\ 0\\.019037140716792165\ \(0\)\
\-\ prior\\:\\ 0\\.018933827884581582\ \(0\)\
\-\ physical\\:\\ 0\\.018349104355862716\ \(0\)\
\-\ increased\\:\\ 0\\.018299341648913333\ \(0\)\
\-\ into\\:\\ 0\\.01798903549048344\ \(0\)\
\-\ noted\\:\\ 0\\.017942191777882394\ \(0\)\
\-\ associated\\:\\ 0\\.017836489368491366\ \(0\)\
\-\ woman\\:\\ 0\\.01762425112870413\ \(0\)\
\-\ most\\:\\ 0\\.01761162901590246\ \(0\)\
\-\ may\\:\\ 0\\.017029614471402346\ \(0\)\
\-\ case\\:\\ 0\\.017001107012514276\ \(0\)\
\-\ have\\:\\ 0\\.016905193707658105\ \(0\)\
\-\ had\\:\\ 0\\.016860589055577628\ \(0\)\
\-\ lateral\\:\\ 0\\.01679430467014031\ \(0\)\
\-\ but\\:\\ 0\\.016734187805098145\ \(0\)\
\-\ multiple\\:\\ 0\\.016552132646275267\ \(0\)\
\-\ surgical\\:\\ 0\\.01644759442091953\ \(0\)\
\-\ contrast\\:\\ 0\\.016442415554786337\ \(0\)\
\-\ after\\:\\ 0\\.01641658882362149\ \(0\)\
\-\ female\\:\\ 0\\.016329609565437855\ \(0\)\
\-\ presents\\:\\ 0\\.016279034742685758\ \(0\)\
\-\ treatment\\:\\ 0\\.016120033177306835\ \(0\)\
\-\ within\\:\\ 0\\.015585897927936477\ \(0\)\
\-\ male\\:\\ 0\\.015067099296058036\ \(0\)\
\-\ that\\:\\ 0\\.014685514663614063\ \(0\)\
\-\ disease\\:\\ 0\\.014205046221657476\ \(0\)\
\-\ be\\:\\ 0\\.013727744276256965\ \(0\)\
\-\ not\\:\\ 0\\.013359430545801975\ \(0\)\
\-\ at\\:\\ 0\\.012781991121539297\ \(0\)\
\-\ for\\:\\ 0\\.010256800538952912\ \(0\)\
\-\ on\\:\\ 0\\.01022041655014957\ \(0\)\
